BB:CC - BridgeBio Pharma files to sell 9.17M shares for holders
2023-11-02 17:34:03 ET
More on BridgeBio Pharma
- BridgeBio: Bets Acoramidis As The Pfizer Spoiler
- BridgeBio: Positive Updated Acoramidis Data May Not Imply Further Upside
- BridgeBio draws Buy rating at Cantor citing 100% upside
- BridgeBio Pharma to issue 9.2M shares through PIPE financing
- Seeking Alpha’s Quant Rating on BridgeBio Pharma
For further details see:
BridgeBio Pharma files to sell 9.17M shares for holders